• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ustekinumab for the treatment of moderate-to-severe plaque psoriasis in a solid organ transplanted recipient: A case report.

作者信息

Richetta Antonio, Marraffa Federica, Grassi Sara, Aquila Emilia, Dybala Agnieszka, Aprile Francesca, Merli Manuela

机构信息

Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.

Department of Precision and Translational Medicine, Centre for the Diagnosis and Treatment of Portal Hypertension, Sapienza University of Rome, Rome, Italy.

出版信息

Australas J Dermatol. 2021 Aug;62(3):e442-e443. doi: 10.1111/ajd.13568. Epub 2021 Feb 26.

DOI:10.1111/ajd.13568
PMID:33634474
Abstract
摘要

相似文献

1
Ustekinumab for the treatment of moderate-to-severe plaque psoriasis in a solid organ transplanted recipient: A case report.优特克单抗治疗实体器官移植受者的中度至重度斑块状银屑病：一例报告。
Australas J Dermatol. 2021 Aug;62(3):e442-e443. doi: 10.1111/ajd.13568. Epub 2021 Feb 26.
2
Risankizumab versus ustekinumab for moderate-to-severe plaque psoriasis.瑞莎珠单抗与优特克单抗治疗中度至重度斑块状银屑病的对比
Dermatol Ther. 2017 Sep;30(5). doi: 10.1111/dth.12507. Epub 2017 May 16.
3
Successful ustekinumab treatment of noninfectious uveitis and concomitant severe psoriatic arthritis and plaque psoriasis.成功使用乌司奴单抗治疗非感染性葡萄膜炎，并伴有严重的银屑病关节炎和斑块型银屑病。
Dermatol Ther. 2017 Sep;30(5). doi: 10.1111/dth.12527. Epub 2017 Aug 18.
4
An analysis of Drug Survival, Effectiveness, and Safety in Moderate to Severe Psoriasis Treated With Ustekinumab: An Observational Study of 69 Patients in Routine Clinical Practice.乌司奴单抗治疗中重度银屑病的药物生存、有效性及安全性分析：一项针对69例常规临床实践患者的观察性研究
Actas Dermosifiliogr (Engl Ed). 2019 Apr;110(3):244-246. doi: 10.1016/j.ad.2018.02.019. Epub 2018 Jun 28.
5
Successful treatment of ustekinumab in a severe psoriasis patient with human immunodeficiency virus infection.优特克单抗成功治疗一名患有人类免疫缺陷病毒感染的重度银屑病患者。
J Eur Acad Dermatol Venereol. 2015 Aug;29(8):1653-5. doi: 10.1111/jdv.12531. Epub 2014 Apr 23.
6
Pharmacogenetics of ustekinumab in patients with moderate-to-severe plaque psoriasis.中度至重度斑块状银屑病患者中优特克单抗的药物遗传学
Pharmacogenomics. 2017 Jan;18(2):157-164. doi: 10.2217/pgs-2016-0122. Epub 2016 Dec 15.
7
Safety of ustekinumab in severe psoriasis with chronic hepatitis B.优特克单抗在伴有慢性乙型肝炎的重度银屑病中的安全性。
Indian J Dermatol Venereol Leprol. 2016 May-Jun;82(3):326-8. doi: 10.4103/0378-6323.174393.
8
Determination of the Nail Psoriasis Severity Index improvement rate standards for nail psoriasis treatment in a phase IV clinical trial of ustekinumab: the MARCOPOLO study.优特克单抗IV期临床试验中指甲银屑病治疗的指甲银屑病严重程度指数改善率标准的确定：MARCOPOLO研究
J Eur Acad Dermatol Venereol. 2017 Jun;31(6):e298-e299. doi: 10.1111/jdv.14083. Epub 2017 Jan 3.
9
Ustekinumab treatment for moderate-to-severe plaque psoriasis: eight-year real-life experience.乌司奴单抗治疗中重度斑块状银屑病：八年真实世界经验。
Expert Opin Biol Ther. 2020 Jan;20(1):95-104. doi: 10.1080/14712598.2020.1684472. Epub 2019 Oct 30.
10
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study.司库奇尤单抗在清除中重度斑块型银屑病患者皮肤方面优于乌司奴单抗：来自 CLEAR 研究的结果。
J Am Acad Dermatol. 2017 Jan;76(1):60-69.e9. doi: 10.1016/j.jaad.2016.08.008. Epub 2016 Sep 20.

引用本文的文献

1
Effectiveness and Safety of Risankizumab for Psoriasis in a Liver Transplant Patient With Recurrent Metastatic Hepatocellular Carcinoma.司库奇尤单抗治疗复发性转移性肝细胞癌肝移植患者银屑病的有效性和安全性
Cureus. 2025 Aug 6;17(8):e89494. doi: 10.7759/cureus.89494. eCollection 2025 Aug.
2
Infections in the era of immunobiologicals.免疫生物制剂时代的感染。
An Bras Dermatol. 2024 Mar-Apr;99(2):167-180. doi: 10.1016/j.abd.2023.08.004. Epub 2024 Jan 17.
3
Case series: psoriasis in solid organ transplant patients and immunobiological agents.
病例系列：实体器官移植患者中的银屑病与免疫生物制剂
An Bras Dermatol. 2023 Sep-Oct;98(5):678-681. doi: 10.1016/j.abd.2022.11.004. Epub 2023 May 16.